Prescription drug · ANDA
Carbidopa NDC 42799-123
Carbidopa 25 mg/1 · Tablet · Oral · Edenbridge Pharmaceuticals LLC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42799-123-01 | 42799012301 | 100 TABLET in 1 BOTTLE (42799-123-01)Marketed from Feb 19, 2016 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Carbidopa
- Generic name (nonproprietary)
- carbidopa
- Active ingredients
- Carbidopa — 25 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205304
- Marketing start
- Listing expires
- Identifiers
- Product ID 42799-123_462dd421-0006-e25d-e063-6294a90ad0efSPL ID 462dd421-0006-e25d-e063-6294a90ad0efSPL set ID 55b99f22-9eb2-4df6-9979-bc4c3af5e454RxCUI 260260UNII MNX7R8C5VOUPC 0342799123011
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442799012301followed by a unit qualifier and the quantityPackage 42799-0123-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Carbidopa tablets are indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson's disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism, which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication. Carbidopa tablets are for use with carbidopa-levodopa in patients for whom the dosage of carbidopa-levodopa tablets provides less than adequate daily dosage (usually 70 mg daily) of carbidopa. Carbidopa tablets are for use with levodopa in the occasional patient whose dosage requirement of carbidopa-levodopa necessitates separate titrati…
Excerpt only. Read the full label for complete information.